| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in (provided by) financing activities | 882,091 | 294,910 |
| (decrease) increase in cash | 9,345 | 26,295 |
| Cash and cash equivalents at beginning of period | 5,046 | - |
| Cash and cash equivalents at end of period | 14,391 | - |
Accustem Sciences Inc. (ACUT)
Accustem Sciences Inc. (ACUT)